Meta facebook tracking pixel
Subscribe to these results:

Upcoming Workshops

  1. Register
  2. Register

Past Workshops

  1. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
  2. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
  3. Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
  4. Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches
  5. What’s New in Precision Medicine
  6. Update on CAR T-Cell Therapies
  7. Follicular Lymphoma: Treatment Progress
  8. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
  9. Non-Hodgkin Lymphoma: Current Treatment Progress
  10. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
  11. Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
  12. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
  13. What’s New In Precision Medicine
  14. Update On Marginal Zone Lymphoma (MZL)
  15. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
  16. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
  17. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
  18. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
  19. Coping with the Stresses of Caregiving When Your Loved One Has Mantle Cell Lymphoma (MCL)Part II of Living with Mantle Cell Lymphoma (MCL)
  20. Diffuse Large B-Cell Lymphoma (DLBCL) Updates
  21. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
  22. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
  23. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
  24. Update on CAR T-Cell Therapies
  25. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
  26. Taking Your Blood Cancer Treatment on Schedule
Back to Top

Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.